Watchlist Price Alert

C4 Therapeutics Inc. (CCCC)

NASDAQ: CCCC · Real-Time Price · USD

1.25

-0.07 (-5.30%)

At close: May 30, 2025, 3:59 PM

1.25

0.40%

After-hours: May 30, 2025, 05:44 PM EDT

-5.30% (1D)

Bid	1.25
Market Cap	88.4M
Revenue (ttm)	39.78M
Net Income (ttm)	-103.28M
EPS (ttm)	-1.48
PE Ratio (ttm)	-0.84
Forward PE	n/a
Analyst	Buy

Ask	1.26
Volume	753,680
Avg. Volume (20D)	1,048,662
Open	1.29
Previous Close	1.32
Day's Range	1.21 - 1.29
52-Week Range	1.08 - 7.66
Beta	3.11

About CCCC

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CCCC

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CCCC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

8 months ago

+13.79%

C4 Therapeutics shares are trading higher after th... Unlock content with Pro Subscription

News

3 weeks ago · zacks.com

C4 Therapeutics, Inc. (CCCC) Reports Q1 Loss, Tops Revenue Estimates

C4 Therapeutics, Inc. (CCCC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.48. This compares to loss of $0.41 per share a year ago.

2 months ago · zacks.com

C4 Therapeutics (CCCC) Loses -21.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

C4 Therapeutics (CCCC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings est...